bioRxivMicrobiologyPreprint
Disruption of the polyuracil tract can greatly enhance immunostimulatory properties of influenza delVGs
- Citations
- 0
Abstract
Non-standard viral genomes (nsVGs) are replication-incompetent genomes within viral populations whose presence has been associated with an enhanced immune response. This association has garnered interest in their use as potential antivirals, vaccine adjuvants, or general immune-modulators. In influenza A virus (IAV), the predominant nsVG is a large deletion in one of the three polymerase segments, which results in deletion-containing viral genomes (delVGs). Work from our group has found that individual delVGs can be recovered that are capable of stimulating high levels of interferon, however we and others have not previously found any consistent means of predicting or modifying determinants of this stimulation. Using high-throughput genetic approaches, we find that specific mutations disrupting the polyuracil tract in IAV delVGs can enhance interferon production by up to two orders of magnitude. Such variants can also associate with improved rescue in artificial systems engineered to exclude infectious virus, and can greatly suppress the growth of replication-competent virus. These findings indicate the polyuracil tract is a key, and unexpected, target for improvement of immunostimulatory delVGs derived from IAV.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Influenza A virus defective viral genomes are inefficiently packaged into virions relative to wild-type genomic RNAs
F. G. Alnaji, W. K. Reiser, … C. B. Brooke·bioRxiv·May 13, 2021
- Sterilization of drug-resistant influenza virus through genetic interference: use of unnatural amino acid-engineered virions
- Influenza A defective viral genome production is altered by metabolites, metabolic signaling molecules, and cyanobacteria extracts
Ilechukwu Agu, Ivy R. José, Samuel L. Díaz‐Muñoz·bioRxiv·Jul 4, 2024
- Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.
R. Rathnasinghe, M. Salvatore, … A. Garcia-Sastre·bioRxiv·Apr 28, 2021
- Replication competent, 10-segmented influenza viruses as antiviral therapeutics
G. D. Haas, A. T. Harding, N. S. Heaton·bioRxiv·Feb 11, 2019
- FLUAV RAM-IGIP: A modified live influenza virus vaccine that enhances humoral and mucosal responses against influenza
C. J. Caceres, L. C. Gay, … D. R. Perez·bioRxiv·Jan 23, 2024